Stimulation of cartilage-matrix proteoglycan synthesis by morphologically transformed chondrocytes grown in the presence of fibroblast growth factor and transforming growth factor-beta.
The effects of transforming growth factor-beta (TGF-beta) on the synthesis of cartilage-matrix proteoglycan by cultured rabbit chondrocytes were examined. Rabbit chondrocytes were seeded at low density and exposed to a 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F-12 medium supplemented with 0.5% fetal bovine serum, 1% bovine serum albumin, 50 micrograms/ml ascorbic acid, and 2 x 10(-7) M hydrocortisone (Medium A). Various combinations of TGF-beta, insulin-like growth factor-I (IGF-I), and fibroblast growth factor (FGF) were also added to Medium A, and the chondrocytes were grown to confluency. Chondrocytes grown with TGF-beta or FGF alone became flat or fibroblastic, those grown with FGF and TGF-beta became very elongated and formed distinct foci, and those grown with FGF and IGF-I showed the spherical configuration characteristic of overtly differentiated chondrocytes. Nevertheless, the incorporation of 3H with glucosamine into the large, chondroitin sulfate proteoglycan synthesized by cultures with FGF and TGF-beta was similar to that in cells grown with FGF and IGF-I and five times that in cells cultured with FGF alone. The increases in incorporation of 3H reflected real increases in proteoglycan synthesis, because chemical analyses showed an increase in the accumulation of macromolecules containing uronic acid in cultures with FGF and TGF-beta or with FGF and IGF-I. However, FGF in combination with either TGF-beta or IGF-I had little effect on the incorporation of 3H into small proteoglycans or hyaluronic acid. These results indicate that chondrocytes morphologically transformed with TGF-beta and FGF fully express the differentiated proteoglycan phenotype rather than the transformed glycosaminoglycan phenotype.
Inoue
H
H
Department of Orthodontics, Faculty of Dentistry, Osaka University, Japan.
Kato
Y
Y
Iwamoto
M
M
Hiraki
Y
Y
Sakuda
M
M
Suzuki
F
F
D000818:Animals; D002358:Cartilage, Articular / Q000166:cytology* / Q000187:drug effects; D002417:Cattle; D005346:Fibroblast Growth Factors / Q000494:pharmacology*; D005944:Glucosamine / Q000493:pharmacokinetics; D006820:Hyaluronic Acid / Q000096:biosynthesis; D008297:Male; D011509:Proteoglycans / Q000096:biosynthesis*; D011817:Rabbits; D015291:Transforming Growth Factors / Q000494:pharmacology*; D014574:Uronic Acids / Q000032:analysis
D011509:Proteoglycans; D014574:Uronic Acids; D005346:Fibroblast Growth Factors; D015291:Transforming Growth Factors; D006820:Hyaluronic Acid; D005944:Glucosamine